Cargando…
Astragalus Flavone Ameliorates Atherosclerosis and Hepatic Steatosis Via Inhibiting Lipid-Disorder and Inflammation in apoE(−/−) Mice
Atherosclerosis is a major pathogenic driver of cardiovascular diseases. Foam cell formation plays a key role in atherogenesis, which is affected by lipid disorder and inflammation. Therefore, inhibition of foam cell formation is a therapeutic approach for atherosclerosis treatment. Total flavone of...
Autores principales: | Ma, Chuanrui, Zhang, Jing, Yang, Shu, Hua, Yunqing, Su, Jing, Shang, Yuna, Wang, Zhongyan, Feng, Ke, Zhang, Jian, Yang, Xiaoxiao, Zhang, Hao, Mao, Jingyuan, Fan, Guanwei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7768082/ https://www.ncbi.nlm.nih.gov/pubmed/33381046 http://dx.doi.org/10.3389/fphar.2020.610550 |
Ejemplares similares
-
Bifunctional supramolecular nanofiber inhibits atherosclerosis by enhancing plaque stability and anti-inflammation in apoE(-/-) mice
por: Shang, Yuna, et al.
Publicado: (2020) -
Formononetin attenuates atherosclerosis via regulating interaction between KLF4 and SRA in apoE(-/-) mice
por: Ma, Chuanrui, et al.
Publicado: (2020) -
The Induction of Endothelial Autophagy and Its Role in the Development of Atherosclerosis
por: Hua, Yunqing, et al.
Publicado: (2022) -
Exploring Ganweikang Tablet as a Candidate Drug for NAFLD Through Network Pharmacology Analysis and Experimental Validation
por: Ma, Chuanrui, et al.
Publicado: (2022) -
HDL/ApoA-1 infusion and ApoA-1 gene therapy in atherosclerosis
por: Chyu, Kuang-Yuh, et al.
Publicado: (2015)